Vital Signs Vitamins and Cancer Risk in Women New York Times, United States - 21 minutes ago There were no differences in rates of breast or colorectal cancer, and no difference in rates of death from cancer or any other cause. ...
Recent News and Articles on the Keywords: breast cancer + cancer + hrt Related to the article below (Last Update: 8/5/2008)
Breast cancer: What you need to know Food Consumer, IL - Applegate, 36, was found to have breast cancer during a routine MRI screening, spokeswoman Ame Van Iden was cited by Reuters as saying in an email. ...
Breast Cancer Self-Exams 'Do More Harm Than Good' RedOrbit, TX - Jul 16, 2008 Despite this, some experts believe the benefits of taking HRT - such as improving quality of life - may outweigh the risks of developing cancer. ...
HRT - New Risks WFtv.com, FL - Jul 15, 2008 A NEW DANGER: New findings from the Fred Hutchinson Cancer Research Center in Seattle reveal HRT can raise the risk of lobular breast cancer by four-fold in ...
Home genetic tests: How much do you really want to know? Independent, UK - Jul 11, 2008 Most of the money came from breast cancer tests. But a backlash has now begun. Critics have begun to say that many of the tests being sold to consumers are ...
Medical Breakthrough -- HRT: New Risks WQAD, IL - Jul 9, 2008 New findings from the Fred Hutchinson Cancer Research Center show HRT increases risk of lobular breast cancer by four-fold in as little as three years ...
Chronic Exposure To Estrogen Impairs Some Cognitive Functions Science Daily (press release) - Aug 1, 2008 ... and a higher than average incidence of breast cancer, cardiovascular disease, blood clots and stroke in women taking estrogen and progesterone. ...
Breast cancer and hormone-replacement therapy: the Million Women Study - V Beral, E Banks, G Reeves, D Bull - The Lancet, 2003 - Elsevier ... Findings that the increased risk of breastcancer in current users of HRT in the
Million Women Study wore off a few years after use ceased are consistent with ...
The use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women. - GA Colditz, SE Hankinson, DJ Hunter, WC Willet, … - Obstetrical & Gynecological Survey, 1995 - obgynsurvey.com ... Menopause, hormone therapy and breastcancer risk. European Journal of Cancer
Prevention. 12(5):437-438, October 2003. La Vecchia, C. ...HRT: Decide Based on the ...
Hormone Replacement Therapy in Relation to Breast Cancer - CL Chen, NS Weiss, P Newcomb, W Barlow, E White - JAMA, 2002 - Am Med Assoc ... The relationship of breastcancer to HRT use in the recent 10-year period was similar
to the results for the recent 5-year analyses (data not shown). COMMENT, ...
Use of HRT and the subsequent risk of cancer. V Beral, E Banks, G Reeves, P Appleby - J Epidemiol Biostat, 1999 - ncbi.nlm.nih.gov ... The effect of HRT on breastcancer wears off after use ceases and has disappeared
largely, if not wholly, within 5 years, whereas the effects on endometrial ...
Source: Google Scholar
Breast Cancer Risk with HRT May Be Lower Than Thought
THURSDAY, Aug. 4 (HealthDay News) -- A new study sounds a note of calm in the sea of concern that has surrounded recent findings on the potential risks of hormone replacement therapy for postmenopausal women.
According to this research, a woman's risk of developing breast cancer while taking combined hormone replacement therapy (HRT) is actually fairly low.
"It really confirms what's been known and what good doctors have been attending to since the Women's Health Initiative published their initial results showing that there could be a problem with breast cancer and HRT," said Dr. Julia Smith, director of the Lynne Cohen Breast Cancer Preventive Care Program at New York University Medical Center/Bellevue, in New York City. "[Combined HRT] could be a short-term option after weighing possible risks, but this has to be done as an individual analysis."
The medical community was stunned when, in 2002, investigators pulled the plug on the Women's Health Initiative trial due to evidence that women taking HRT had a higher incidence of heart attacks, stroke, blood clots and breast cancer.
Although HRT is approved to alleviate menopausal symptoms, based largely on observational data, doctors had been prescribing hormones to women to prevent cardiovascular problems.
"For years, doctors told people this medicine prevents heart disease," said Dr. Jay Brooks, chairman of hematology/oncology at the Ochsner Clinic Foundation in New Orleans. "It doesn't. It increases the risk of heart disease."
A more recent study confused matters even more by suggesting that estrogen, when given alone, may not increase the risk of breast cancer.
The authors of the new study, which appears in the Aug. 6 issue of the British Medical Journal, tried to sort through the confusion by assessing risk from an individual perspective.
The researchers, based at the New South Wales Breast Cancer Institute in Australia, estimated the individual breast cancer risk of women up to 79 years of age, something known as cumulative absolute risk.
The cumulative absolute risk of breast cancer declined as a woman aged, as long as she was not taking combined HRT, meaning estrogen and progestin.
For women aged 40 to 79 who are not using HRT, the average risk of breast cancer is 7.2 percent (one in 14); at 50 years of age, it is 6.1 percent (one in 16); and at 60 years, it is 4.4 percent (one in 23).
When combined HRT is added, however, the risk starts to climb. A woman taking HRT for five years starting at age 55 has an additional risk of 0.6 percent. If she takes it for 10 years, the risk climbs to 1.8 percent.
Once the therapy is stopped, however, risk returns to that of a woman of the same age who has never used hormones, the study stated.
The increased risk was even less if the woman used estrogen alone: 6.3 percent (an extra risk of 0.2 percent) at five years.
There are very real, documented problems with using estrogen alone, however.
"If a woman has a uterus, you cannot give estrogen alone because there's no question that it increases uterine cancer," Smith said. "There are also very serious health issues related to giving estrogen, including the risk of stroke."
Once again, it comes down to the individual woman.
"If you have a woman who is going through menopause or has gone through menopause and has severe, severe symptoms and her quality of life is untenable, you look at her other medical problems and you see that she's youngish and has no obvious risk for heart attack, stroke or thromboembolic problems, you may give her a short course of HRT," Smith said.
If not, then you start looking at other ways to alleviate symptoms, such as diet and exercise and other drugs, including certain antidepressants.
"It shows that the risk [revealed in the new study] is small but you have to understand that this is for breast cancer only, not heart disease, which is another risk," Brooks said. "You have to ask yourself, 'Do I want a medicine that may increase my risk for breast cancer, heart disease and stroke to alleviate symptoms that are not going to kill me, that are going to get better in over 85 percent of all women with time.' That's the question individual women have to raise."